|1.||Ma, Julian K: 1 article (03/2011)|
|2.||Paul, Mathew J: 1 article (03/2011)|
|3.||Pepponi, Ilaria: 1 article (03/2011)|
|4.||Stylianou, Elena: 1 article (03/2011)|
|5.||van Dolleweerd, Craig J: 1 article (03/2011)|
|6.||Reljic, Rajko: 1 article (03/2011)|
|7.||Teichberg, Saul: 1 article (03/2007)|
|8.||Singh, Priyanka: 1 article (03/2007)|
|9.||Hatsukari, Ikusuke: 1 article (03/2007)|
|10.||Singhal, Pravin C: 1 article (03/2007)|
10/01/1996 - "Differential expression of gp200-MR6 molecule in benign hyperplasia and down-regulation in invasive carcinoma of the breast."
10/01/1996 - "In this study, we used immunohistochemical and biochemical analysis to show that gp200-MR6, a 200 kDa molecule that is functionally associated with the human interleukin 4 (IL-4) receptor complex, is expressed at high levels on normal breast epithelial tissues, at lower levels on in situ carcinomas, and that the expression is lost in the invasive carcinoma of the breast. "
05/16/1997 - "We have previously shown that expression of gp200-MR6, a molecule that is functionally associated with the interleukin-4 receptor (IL-4R), is lost from breast carcinoma cells as malignancy increases. "
02/01/1996 - "Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124)."
03/09/2011 - "Dec-205 receptor expressed by several subsets of DC has been shown in previous studies to be an efficient endocytic receptor for inducing both humoral and cellular immune responses, but this immunisation approach has not been tested in an experimental model of infection. "
03/01/2007 - "Moreover, expression of DEC-205 in cells that lack the DEC-205 receptors renders them susceptible to HIV-1 infection. "
03/09/2011 - "We investigated if antigen targeting to the endocytic cell receptor Dec-205 on dendritic cells (DCs) could induce a protective immune response to Mycobacterium tuberculosis (MTB) infection in the absence of conventional adjuvants. "
|5.||Breast Neoplasms (Breast Cancer)
11/01/1996 - "It is concluded that loss of gp200-MR6 may be one of the mechanisms through which breast cancer cells escape immune surveillance, resulting in an increased metastatic potential and poorer outcome. "
11/01/1996 - "The normal breast epithelia were invariably stained for gp200-MR6 showing that down-regulation or loss of this molecule occurred during the evolution of breast cancer. "
10/01/1996 - "These results suggest that analysis of gp200-MR6 expression may be useful in tumour grading and prognostic evaluation in breast cancer. "
11/01/1996 - "Loss of interleukin 4 receptor-associated molecule gp200-MR6 in human breast cancer: prognostic significance."
|1.||Interleukin-4 (Interleukin 4)
|2.||Interleukin-4 Receptors (Interleukin 4 Receptor)
|3.||C-Type Lectins (C-Type Lectin)
|4.||Messenger RNA (mRNA)
|6.||butyl 3-(1H-tetrazol-5-yl)oxanilate (MTB)